Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer (Q28268250)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16112269%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16112269%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16112269%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Robert Clarke

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16112269%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

3

Minetta C Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16112269%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Amy H Bouton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16112269%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16112269%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

published in

Vitamins and Hormones

2 references

DOI.org query endpoint

https://doi.org/10.1016%2FS0083-6729%2805%2971007-4

9 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16112269%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16112269%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

201-237

2 references

DOI.org query endpoint

https://doi.org/10.1016%2FS0083-6729%2805%2971007-4

9 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16112269%20AND%20SRC:MED&resulttype=core&format=json

Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients.

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

The pipeline of new anticancer agents for breast cancer treatment in 2003

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety upda

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Rap1 signalling: adhering to new models

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Functions of the adapter protein Cas: signal convergence and the determination of cellular responses

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Regulation of c-SRC activity and function by the adapter protein CAS

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

The role of SRC-CAS interactions in cellular transformation: ectopic expression of the carboxy terminus of CAS inhibits SRC-CAS interaction but has no effect on cellular transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Tyrosine phosphorylation of p130(cas) by bombesin, lysophosphatidic acid, phorbol esters, and platelet-derived growth factor. Signaling pathways and formation of a p130(cas)-Crk complex

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Shaping the nuclear action of NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

An introduction to the molecular mechanisms of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Role of endocrine therapy in the neoadjuvant surgical setting

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Interferon regulatory factor expression in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Tamoxifen resistance in breast cancer: elucidating mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

A cellular poison cupboard

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Tamoxifen and the farnesyl transferase inhibitor FTI-277 synergize to inhibit growth in estrogen receptor-positive breast tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Preoperative endocrine therapy for older women with breast cancer: renewed interest in an old idea

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Neoadjuvant comparisons of aromatase inhibitors and tamoxifen: pretreatment determinants of response and on-treatment effect

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

p53-independent dephosphorylation and cleavage of retinoblastoma protein during tamoxifen-induced apoptosis in human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Modulation of TRAIL signaling for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Hormonal regulation of apoptosis in breast cells and tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Quality of health care delivered to adults in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

p130Cas regulates the activity of AND-34, a novel Ral, Rap1, and R-Ras guanine nucleotide exchange factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

BCL-2 family members and the mitochondria in apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Amplification of HSD17B1 and ERBB2 in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

The multifaceted mechanisms of estradiol and estrogen receptor signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Overcoming resistance of cancer cells to apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Do estrogens always increase breast cancer risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Recent advances in endocrine therapy of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Estrogen receptor-mediated direct and indirect antitumor effects of tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

1 reference

7 January 2021

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Estrogen receptor pathways to AP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Estrogen receptor phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Ductal carcinoma in situ, complexities and challenges.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Regulation of death promoter Bak expression by cell density and 17 beta-estradiol in MCF-7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Apoptosis in the absence of caspase 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Altered subcellular localization of p53 in estrogen-dependent and estrogen-independent breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

The TNF and TNF receptor superfamilies: integrating mammalian biology

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

NSP1 defines a novel family of adaptor proteins linking integrin and tyrosine kinase receptors to the c-Jun N-terminal kinase/stress-activated protein kinase signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Targeting the PI3K-Akt pathway in human cancer: rationale and promise

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Mechanisms of tamoxifen-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

The nuclear receptor superfamily: the second decade

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Aromatase inhibitors and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Biological rationale for endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Apoptotic mechanisms in T47D and MCF-7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Regulation of fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

ER beta: identification and characterization of a novel human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Tumour necrosis factor and interferon are selectively cytostatic in vitro for hormone-dependent and hormone-independent human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Estrogen receptors: how do they control reproductive and nonreproductive functions?

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Tamoxifen induces apoptosis in Fas+ tumor cells by upregulating the expression of Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Proteasome-dependent degradation of the human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Ectopic expression of cyclin D1 amplifies a retinoic acid-induced mitochondrial death pathway in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Epidermal growth factor modulates tyrosine phosphorylation of p130Cas. Involvement of phosphatidylinositol 3'-kinase and actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Genistein-induced apoptosis in MCF-7 cells involves changes in Bak and Bcl-x without evidence of anti-oestrogenic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Growth arrest of the breast cancer cell line, T47D, by TNF alpha; cell cycle specificity and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

A growing family of guanine nucleotide exchange factors is responsible for activation of ras-family GTPases

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Synergistic promotion of c-Src activation and cell migration by Cas and AND-34/BCAR3.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Mechanisms of CAS substrate domain tyrosine phosphorylation by FAK and Src

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Interferon-gamma and TRAIL in human breast tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

The up-regulation of human caspase-8 by interferon-gamma in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Bcl-xl antisense treatment induces apoptosis in breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Antiestrogens are pro‐apoptotic in normal human breast epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Linkage of Rapid Estrogen Action to MAPK Activation by ER -Shc Association and Shc Pathway Activation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Apoptotic action of estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Oestrogen receptor beta in breast cancer: good, bad or still too early to tell?

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Oestrogen receptor beta: what it means for patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Estradiol rapidly activates Akt via the ErbB2 signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

1 reference

7 January 2021

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Identification of a caspase 3-independent role of pro-apoptotic factor Bak in TNF-alpha-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Normal breast epithelial cells induce apoptosis of breast cancer cells via Fas signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i).

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Mitochondrial localization of estrogen receptor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Involvement of R-Ras and Ral GTPases in estrogen-independent proliferation of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2805%2971007-4

7 January 2021

10.1016/S0083-6729(05)71007-4

Identifiers

DOI

2 references

DOI.org query endpoint

https://doi.org/10.1016%2FS0083-6729%2805%2971007-4

9 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16112269%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference